ARGENICA THERAPEUTICS LIMITED (AGN)
AI Coverage Rating: Moderate
ASX AI Signals has generated 2 signal(s) for AGN during the last 90 days,
indicating Moderate trading activity
Latest AGN Signals |
| 25/06/2026 | SELL |
| 08/05/2026 | SELL |
AGN Share Price |
| Current Price | $0.120 |
| 52 Week High | $0.730 |
| 52 Week Low: | $0.090 |
| Trading at (% of 52 Week High) | 16.44% |
Volume
240776
20 Day Avg
587431
Relative Volume
41.0%
Business Overview
Argenica Therapeutics Limited (ASX: AGN) is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company specializes in targeted treatments using its proprietary technology platforms to improve patient outcomes.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The SELL recommendation for ARGENICA THERAPEUTICS LIMITED (AGN) is supported by the current low stock price indicating potential undervaluation concerns, combined with market signals pointing to downward momentum. However, the confidence is moderated by limited publicly available financial data and potential volatility in the biotech sector.
Latest ARGENICA THERAPEUTICS LIMITED(AGN) News
06 May 2025, 06:02 AM
The Australian stock market recently experienced a downturn, with the ASX200 closing down 0.97% at 8,157 points, and sectors like Energy and Financials leading the decline. Despite these broader market challenges, penny stocks continue to capture investor interest due to their potential for signific
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial